Biphenomycins, natural products derived from bacteria, show excellent antimicrobial activity, but have long remained out of ...

Following today's meeting with the FDA concerning IBT's live biotherapeutic product, IBT has decided to pursue an accelerated approval pathway for IBP-9414. The FDA's Accelerated Approval Program allo ...

Bacteria that produce many antibiotics use a surprising self-poisoning system to coordinate development. Sensing a key signal triggers a pathway creating toxic byproducts, but only those bacteria able ...

An international research team has uncovered a surprising ally in the fight against insulin resistance and type 2 diabetes: a ...

Infant Bacterial Therapeutics AB ( ($SE:IBT.B) ) just unveiled an announcement. Infant Bacterial Therapeutics AB has decided to pursue an ...

A disease that has stalked humanity for millennia may have finally met its match. Mycobacterium tuberculosis, the pathogen ...

New research suggests habitual nose picking could damage the nasal lining, allowing bacteria to enter the brain via the ...

USAntibiotics, the country's only domestic manufacturer of amoxicillin (Amoxil®) and amoxicillin clavulanate (Augmentin®), ...

A Swediah biopharma company developing live biotherapeutic products for diseases affecting premature infants, led by IBP-9414 ...

The PrIMAVeRa project develops a platform to evaluate how mAbs can combat AMR by reducing antibiotic use and providing ...